Home / Resource Library / Improving Risk/Benefit of Frontline Classical Hodgkin Lymphoma TreatmentImproving Risk/Benefit of Frontline Classical Hodgkin Lymphoma Treatment NCCN Congress 2021: Options for first line treatment of Hodgkin lymphoma are discussed.